How to Interpret Your Fertility Blood Results: AMH, FSH and LH

Fertility blood tests can provide useful information about ovarian reserve, ovulation and the way the reproductive hormones are working together. AMH, FSH and LH are often discussed as if they offer a simple measure of fertility, but each hormone answers a different question and must be interpreted alongside age, menstrual history, ultrasound findings and, where relevant, sperm health.

For people arranging testing in Australia, the process may involve a GP referral, a private pathology provider or a fertility clinic in Melbourne, Sydney, Brisbane, Perth or another centre. Some tests may attract a Medicare rebate while others are privately billed, and reference ranges can vary between laboratories. A result should therefore be reviewed with the clinician who understands the testing method and your personal circumstances.

What AMH can and cannot tell you

Anti-Müllerian hormone, usually shortened to AMH, is produced by small follicles in the ovaries. Its main clinical use is to estimate ovarian reserve, meaning the approximate number of eggs remaining. AMH can be measured on most days of the menstrual cycle, which makes it convenient when appointments do not align with a particular cycle date.

A lower AMH may suggest a reduced number of recruitable follicles and a potentially lower response to ovarian stimulation during IVF. It does not prove that natural conception is impossible, and it does not directly measure egg quality. Egg quality is strongly associated with age, while AMH is primarily associated with egg quantity. A person with a low AMH may still conceive, particularly if other factors are favourable.

A higher AMH often indicates a larger follicle pool and may predict a stronger response to fertility medicines. It can also be seen in people with polycystic ovary syndrome, or PCOS, especially when combined with irregular periods, acne, excess facial or body hair, or polycystic ovarian morphology on ultrasound. A high result is not automatically a sign of excellent fertility. It can sometimes indicate a greater risk of ovarian hyperstimulation during treatment, so medication doses need careful planning.

AMH results are reported in different units, including pmol/L and ng/mL. Age-specific interpretation matters, and there is no single number that defines fertility for everyone. Hormonal contraception, recent pregnancy, some ovarian conditions and laboratory variation may influence the result. A fertility specialist may use AMH with an antral follicle count rather than relying on the blood test alone.

Understanding FSH and the timing of the test

Follicle-stimulating hormone, or FSH, helps stimulate follicles to grow in the ovaries. It is generally measured early in the menstrual cycle, commonly on day two, three or four. Day one is usually counted as the first day of proper menstrual bleeding, rather than light spotting. The exact timing should follow the instructions from the doctor or pathology service.

An elevated early-cycle FSH can mean the ovaries require more stimulation from the brain to recruit follicles. This may be associated with diminished ovarian reserve, particularly when it is repeatedly high. However, FSH can vary from cycle to cycle, so one abnormal result is not always definitive. Testing estradiol at the same time is useful because a higher early-cycle estradiol level can temporarily suppress FSH and make the result appear more reassuring than it is.

A normal FSH does not guarantee normal egg quantity or quality. It is possible to have an acceptable FSH with a low AMH or a low antral follicle count. The reverse can also occur. Doctors usually consider the whole pattern, including age, menstrual regularity, previous ovarian surgery, chemotherapy exposure, endometriosis and the response to any earlier treatment.

FSH is also relevant in men, where it reflects part of the hormonal signal supporting sperm production. A raised level may indicate impaired testicular function, while a low or inappropriately normal level can occur when signalling from the pituitary or hypothalamus is reduced. It should be assessed with testosterone, LH and a semen analysis rather than interpreted in isolation.

What LH reveals about ovulation

Luteinising hormone, known as LH, triggers ovulation after a developing follicle has matured. An LH surge is what causes the follicle to release an egg. Home urine ovulation kits detect this surge, while a blood test provides a snapshot of the hormone level at a particular point in the cycle.

A single LH measurement is difficult to interpret without knowing the cycle day. LH may be low or moderate during the early follicular phase, rise sharply before ovulation and then fall. A blood test taken after ovulation may be used with progesterone to assess whether ovulation has occurred. For some patients, ultrasound monitoring and repeated blood tests provide a clearer picture than one isolated LH result.

People with PCOS may have an increased baseline LH, although this pattern is not present in everyone and is not required for diagnosis. An elevated LH-to-FSH ratio is sometimes discussed, but the ratio alone cannot diagnose PCOS or predict fertility. Irregular or absent ovulation, clinical symptoms, ultrasound findings and other causes must be assessed.

LH is part of the evaluation for male infertility as well. Alongside FSH and testosterone, it can help distinguish a problem with testicular sperm production from a problem involving hormonal signalling. Medication use, significant weight changes, intense exercise, chronic illness and pituitary conditions can all affect reproductive hormones.

Reading the results as a complete picture

AMH, FSH and LH are most helpful when viewed alongside antral follicle count, ovarian ultrasound, cycle history and the reason for testing. A person with regular ovulation and a low AMH may have a different treatment outlook from someone with a similar result, irregular cycles and evidence of PCOS. Age, previous pregnancy, endometriosis, tubal health and sperm factors also influence the chance of conceiving.

These tests do not assess whether the fallopian tubes are open, whether the uterus is suitable for implantation or whether sperm can reach and fertilise an egg. Depending on the situation, evaluation may include a semen analysis, pelvic ultrasound, tubal patency testing and screening for conditions such as thyroid dysfunction or high prolactin. Fertility is a shared reproductive issue, so testing both partners early can prevent avoidable delays.

Reference intervals printed on an Australian pathology report are population-based guides rather than personal fertility targets. A result just outside the range may have little practical significance, while a result within the range may still need investigation if periods are absent or conception has not occurred. Some laboratories use different assays, and results from separate providers should not be compared casually.

Access also varies across Australia. A GP can arrange initial blood tests and refer to a reproductive endocrinologist, while private fertility clinics may offer direct appointments and bundled testing. Medicare rebates, private health insurance policies and out-of-pocket fees differ, and publicly funded IVF places may have eligibility rules and waiting periods. Patients travelling from regional areas may combine pathology, ultrasound and telehealth appointments to reduce time away from work.

Using hormone results to plan treatment

The purpose of fertility blood testing is to guide decisions rather than label someone as fertile or infertile. A lower ovarian reserve estimate may lead a specialist to discuss trying sooner, IVF, embryo freezing or a stimulation protocol designed to collect available follicles efficiently. It does not necessarily mean that donor eggs are immediately required. A higher AMH with PCOS may lead to a gentler protocol intended to reduce the risk of ovarian hyperstimulation syndrome.

Treatment choices are individual. Depending on the findings, a plan might involve timed intercourse, ovulation induction, intrauterine insemination, IVF, ICSI or fertility preservation. If donor sperm is being considered, a specialist can explain screening, storage, consent and treatment pathways; this donor sperm overview can provide useful background before an appointment. Donor arrangements in Australia involve regulated clinic processes, counselling and record-keeping requirements, with some details differing between states and territories.

Australian assisted reproductive technology is delivered within state and territory legal frameworks and professional standards, including clinic accreditation requirements. Donor-conceived people may have rights to access identifying or medical information depending on the jurisdiction and the circumstances of conception. Surrogacy, embryo storage and donor treatment also have specific legal and consent considerations, so a clinic should explain the rules that apply to the patient’s location.

General health remains relevant while test results are being interpreted. Stopping smoking, moderating alcohol, reviewing medicines, maintaining a sustainable weight and taking recommended preconception folate can support treatment preparation. Fertility care can also be emotionally demanding, particularly when appointments are fitted around shift work, school runs or long commutes. Counselling and practical support are legitimate parts of care, not signs that the laboratory results are being dismissed.

A fertility assessment should also separate reproductive questions from unrelated symptoms. For example, persistent or worsening neck pain needs appropriate medical review rather than being attributed to hormone changes; guidance on when neck pain persists explains when specialist assessment may be appropriate. Keeping separate health concerns visible helps clinicians make safer decisions about medications, procedures and overall wellbeing.

Bring the pathology report, cycle dates, medication list, previous scan results and any history of pregnancy or pelvic surgery to your appointment. Indo Nippon IVF provides appointment-based reproductive care, advanced laboratory support and personalised treatment planning for patients in India and overseas. Arrange a consultation to have AMH, FSH and LH interpreted as part of a complete fertility assessment and to discuss the treatment pathway that best fits your circumstances.